Active	Status	Sponsor type	Region	Phase	Filter
15 Active 4 Inactive 19 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

1 Trials

Active Trials   Industry lead sponsorIndustry collaborator

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Censi, Andrea De
CANAL, NCT05725343: A Prevention Trial of Canakinumab in Subjects at High Risk for Lung Cancer	Terminated	3	350	Europe	Canakinumab, ilaris, Placebo	Mario Negri Institute for Pharmacological Research, Novartis Pharmaceuticals	Lung Cancer	04/22	09/22
Provinciali, Nicoletta
No trials found